Forskning ved Københavns Universitet - Københavns Universitet

Forside

[18F]FLT and [18F]FDG PET for non-invasive treatment monitoring of the nicotinamide phosphoribosyltransferase inhibitor APO866 in human xenografts

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

APO866 is a new anti-tumor compound inhibiting nicotinamide phosphoribosyltransferase (NAMPT). APO866 has an anti-tumor effect in several pre-clinical tumor models and is currently in several clinical phase II studies. 3'-deoxy-3'-[18F]fluorothymidine ([18F]FLT) is a tracer used to assess cell proliferation in vivo. The aim of this study was non-invasively to study effect of APO866 treatment on [18F]FLT and 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) uptake.
OriginalsprogEngelsk
Artikelnummere53410
TidsskriftP L o S One
Vol/bind8
Udgave nummer1
Sider (fra-til)1-8
Antal sider9
ISSN1932-6203
DOI
StatusUdgivet - 2013

ID: 45864162